HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Bortolotti, U. Articles by Mazzucco, A. Search for Related Content PubMed PubMed Citation Articles by Bortolotti, U. Articles by Mazzucco, A.

Eur J Cardiothorac Surg 2006;6:S75-S78
© 2006 Elsevier Science NL

Original expectations of the Hancock valve and 20 years of clinical reality

^a Department of Cardiovascular Surgery, University of Padova Medical School, Padova, Italy
^b Department of Pathology, University of Padova Medical School, Padova, Italy

The standard (glutaraldehyde-preserved) Hancock porcine bioprosthesis was introduced into clinical practice in order to provide surgeons with a cardiac valve substitute which would be nonthrombogenic and therefore would not require anticoagulation, and would be durable, anatomically suitable, and noiseless. In the present report we have reviewed our long-term experience with Hancock porcine valve recipients in order to verify whether the original expectations of this bioprosthesis have been met.

Key Words: Porcine bioprosthesis • Hancock porcine valve • Long-term follow-up